Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-0646
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response ; volume:28 ; number:3 ; day:16 ; month:9 ; year:2009 ; pages:326-333 ; date:6.2010
Investigational new drugs ; 28, Heft 3 (16.9.2009), 326-333, 6.2010
- Urheber
-
Ma, Brigette B.Y
Lui, Vivian W.Y
Poon, Fan Fong
Wong, S.C. Cesar
To, Ka Fai
Wong, Elaine
Chen, Honglin
Lo, Kwok Wai
Tao, Qian
Chan, Anthony T.C
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10637-009-9316-7
- URN
-
urn:nbn:de:101:1-2019072821171852205430
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ma, Brigette B.Y
- Lui, Vivian W.Y
- Poon, Fan Fong
- Wong, S.C. Cesar
- To, Ka Fai
- Wong, Elaine
- Chen, Honglin
- Lo, Kwok Wai
- Tao, Qian
- Chan, Anthony T.C
- SpringerLink (Online service)
Ähnliche Objekte (12)
Erratum to: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
Clinical and Preclinical Experience with Gefitinib and Sunitinib
MiRNA-125a-5p: a regulator and predictor of gefitinib’s effect on nasopharyngeal carcinoma
Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coatingGefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
A New Synthesis of Gefitinib
Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation
Evaluation of novel Epstein-Barr virus serological biomarkers for nasopharyngeal carcinoma
Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance
Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma
Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
Erratum to: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
Clinical and Preclinical Experience with Gefitinib and Sunitinib
MiRNA-125a-5p: a regulator and predictor of gefitinib’s effect on nasopharyngeal carcinoma
Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coatingGefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
A New Synthesis of Gefitinib
Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation
Evaluation of novel Epstein-Barr virus serological biomarkers for nasopharyngeal carcinoma
Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance
Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma
Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
Erratum to: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
Clinical and Preclinical Experience with Gefitinib and Sunitinib
MiRNA-125a-5p: a regulator and predictor of gefitinib’s effect on nasopharyngeal carcinoma
Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coatingGefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
A New Synthesis of Gefitinib
Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation
Evaluation of novel Epstein-Barr virus serological biomarkers for nasopharyngeal carcinoma
Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance
Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma